Login to Your Account

Other News To Note

Wednesday, October 5, 2011
X-Body Inc., of Waltham, Mass., inked a partnership with Tanabe Research Laboratories U.S.A. Inc. (TRL), an independent subsidiary of Mitsubishi Tanabe Pharma Corp., of Osaka, Japan. Under terms of the agreement, X-Body will screen its antibody libraries against target cells of therapeutic interest to TRL to identify tissue-specific epitopes and human antibody therapeutic candidates in autoimmune disease.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription